Liver Institute Northwest Participating in RESPONSE, a Global Phase 3 Clinical Research Study Evaluating an Investigational Therapy for the Treatment of Primary Biliary Cholangitis (PBC)
February 01, 2022 08:30 ET
|
Liver Institute Northwest
SEATTLE, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Liver Institute Northwest is enrolling participants into RESPONSE, a global phase 3 clinical research study evaluating the safety and efficacy of...